Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide
Xtalks
Wed, 06/8/22 - 11:04 pm
Novartis
Sandoz
biosimilars
generics
Bristol Myers settles anti-generic HIV drug scheme allegations for almost $11M
Endpoints
Wed, 06/8/22 - 10:18 am
Bristol Myers Squibb
legal
HIV
generics
competition
California
J&J takes Aurobindo to court over potential Erleada generic
Endpoints
Tue, 05/31/22 - 11:53 pm
JNJ
Aurobindo
legal
generics
Erleada
J&J's Momenta calls infringement against Viatris' Copaxone generic, but why now?
Fierce Pharma
Thu, 05/26/22 - 10:46 am
JNJ
Momenta Pharmaceuticals
Viatris
Copaxone
generics
drug manufacturing
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Endpoints
Mon, 05/23/22 - 10:16 am
Europe
India
CROs
generics
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Teva settlement prevents Lupin from launching its Austedo generic until 2033
Fierce Pharma
Mon, 05/2/22 - 06:34 pm
Teva Pharmaceutical
tardive dyskinesia
Austedo
Lupin
generics
AstraZeneca staves off last Tagrisso copycat with settlement—for now
Fierce Pharma
Wed, 04/27/22 - 10:40 pm
AstraZeneca
Tagrisso
patents
legal
Alembic Pharmaceuticals
generics
Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court
Fierce Pharma
Fri, 04/15/22 - 01:54 pm
JNJ
Bristol Myers Squibb
Gilead Sciences
HIV
legal
anticompetitive practices
generics
FDA’s legislative wish list includes device cybersecurity, a generic exclusivity fix, and more
RAPS.org
Mon, 04/4/22 - 11:15 pm
FDA
regulatory
cybersecurity
MDUFA
devices
Medtech
generics
Roche comes up short in its attempt to hold off generic competition to Esbriet
Endpoints
Thu, 03/24/22 - 08:38 pm
Roche
Esbriet
IPF
generics
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week
Fierce Pharma
Wed, 03/23/22 - 10:58 pm
Novartis
Sandoz
product recalls
generics
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Novo Nordisk
Novartis
Sandoz
Victoza
generics
patents
diabetes
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Viatris
AstraZeneca
generics
FDA
Symbicort
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Novartis
Sandoz
generics
M&A
Coalesce Product Development
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch
Fierce Pharma
Mon, 03/7/22 - 10:51 pm
Bristol Myers Squibb
Revlimid
Multiple Myeloma
generics
Teva Pharmaceutical
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
Endpoints
Sun, 02/20/22 - 11:52 am
PBMs
drug pricing
generics
Generic drug approvals continued to fall in 2021
RAPS.org
Wed, 02/16/22 - 11:13 pm
FDA
generics
Is the battle over 'skinny' generic labels headed to the Supreme Court?
Endpoints
Wed, 02/16/22 - 11:10 pm
Teva Pharmaceutical
generics
skinny labels
Court sides with Teva over Emergent in generic Narcan suit
Endpoints
Tue, 02/15/22 - 11:36 pm
Teva Pharmaceutical
legal
Emergent BioSolutions
generics
Narcan
opioids
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »